Vir Biotechnology, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $423.9M | $109.3M |
| FY2020 | — | $716.9M | $436.6M |
| FY2021 | — | $1.43B | $347.8M |
| FY2022 | — | $2.08B | $848.6M |
| FY2023 | — | $1.59B | $241.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $423.9M | $109.3M |
| FY2020 | — | $716.9M | $436.6M |
| FY2021 | — | $1.43B | $347.8M |
| FY2022 | — | $2.08B | $848.6M |
| FY2023 | — | $1.59B | $241.6M |